Beatrice Zitti

Dr. Beatrice Zitti


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Science
Verified
Journal Article
Closed access
RBRuben Bill
Ruben Bill
PWPratyaksha Wirapati
Pratyaksha Wirapati
MMMarius Messemaker
Marius Messemaker
WRWhijae Roh
Whijae Roh
BZBeatrice Zitti
Beatrice Zitti
MPMikael J. Pittet
Mikael J. Pittet
Tumor microenvironments (TMEs) influence cancer progression but are complex and often differ between patients. Considering that microenvironment variations may reveal rules governing intratumoral cellular programs and disease outcome, we focused on tumor-to-tumor variation to examine 52 head and neck squamous cell carcinomas. We found that macrophage polarity—defined by CXCL9 and SPP1 (CS) expression but not by conventional M1 and M2 markers—had a noticeably strong prognostic association. CS macrophage polarity also identified a highly coordinated network of either pro- or antitumor variables, which involved each tumor-associated cell type and was spatially organized. We extended these findings to other cancer indications. Overall, these results suggest that, despite their complexity, TMEs coordinate coherent responses that control human cancers and for which CS macrophage polarity is a relevant yet simple variable.

1 August 2018 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
BZBeatrice Zitti
Beatrice Zitti
YBYenan T. Bryceson
Yenan T. Bryceson

Verified
Journal Article
Open access
PDF file
RMRosa Molfetta
Rosa Molfetta
BZBeatrice Zitti
Beatrice Zitti
MLMario Lecce
Mario Lecce
NMNadia Domenica Milito
Nadia Domenica Milito
HSHelena Stabile
Helena Stabile
RPRossella Paolini
Rossella Paolini
CD155 is an adhesion molecule belonging to the Nectin/Nectin-like family often overexpressed on tumor cells and involved in many different processes such as cell adhesion, migration and proliferation. In contrast to these pro-tumorigenic functions, CD155 is also a ligand for the activating receptor DNAM-1 expressed on cytotoxic lymphocytes including Natural Killer (NK) cells and involved in anti-tumor immune response. However, during tumor progression inhibitory receptors for CD155 are up-regulated on the surface of effector cells, contributing to an impairment of their cytotoxic capacity. In this review we will focus on the roles of CD155 as a ligand for the activating receptor DNAM-1 regulating immune surveillance against cancer and as pro-oncogenic molecule favoring tumor proliferation, invasion and immune evasion. A deeper understanding of the multiple roles played by CD155 in cancer development contributes to improving anti-tumor strategies aimed to potentiate immune response against cancer.

15 September 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AVAlejandro V. Villarino
Alejandro V. Villarino
GSGiuseppe Sciume
Giuseppe Sciume
FDFred P. Davis
Fred P. Davis
SIShigeru Iwata
Shigeru Iwata
BZBeatrice Zitti
Beatrice Zitti
JOJohn J. O’shea
John J. O’shea
Innate lymphoid cells (ILCs) patrol environmental interfaces to defend against infection and protect barrier integrity. Using a genetic tuning model, we demonstrate that the signal-dependent transcription factor (TF) STAT5 is critical for accumulation of all known ILC subsets in mice and reveal a hierarchy of STAT5 dependency for populating lymphoid and nonlymphoid tissues. We apply transcriptome and genomic distribution analyses to define a STAT5 gene signature in natural killer (NK) cells, the prototypical ILC subset, and provide a systems-based molecular rationale for its key functions downstream of IL-15. We also uncover surprising features of STAT5 behavior, most notably the wholesale redistribution that occurs when NK cells shift from tonic signaling to acute cytokine-driven signaling, and genome-wide coordination with T-bet, another key TF in ILC biology. Collectively, our data position STAT5 as a central node in the TF network that instructs ILC development, homeostasis, and function and provide mechanistic insights on how it works at cellular and molecular levels.

14 April 2023 in Science Immunology
Verified
Journal Article
Closed access
EHEric Y. Helm
Eric Y. Helm
Tomas ZelenkaTomas Zelenka
Tomas Zelenka
VCValeriu B. Cismasiu
Valeriu B. Cismasiu
SIShamima Islam
Shamima Islam
LSLeonardo Silvane
Leonardo Silvane
DADorina Avram
Dorina Avram
The networks of transcription factors (TFs) that control intestinal-resident memory CD8 + T (T RM ) cells, including multipotency and effector programs, are poorly understood. In this work, we investigated the role of the TF Bcl11b in T RM cells during infection with Listeria monocytogenes using mice with post-activation, conditional deletion of Bcl11b in CD8 + T cells. Conditional deletion of Bcl11b resulted in increased numbers of intestinal T RM cells and their precursors as well as decreased splenic effector and circulating memory cells and precursors. Loss of circulating memory cells was in part due to increased intestinal homing of Bcl11b −/− circulating precursors, with no major alterations in their programs. Bcl11b −/− T RM cells had altered transcriptional programs, with diminished expression of multipotent/multifunctional (MP/MF) program genes, including Tcf7 , and up-regulation of the effector program genes, including Prdm1. Bcl11b also limits the expression of Ahr, another TF with a role in intestinal CD8 + T RM cell differentiation. Deregulation of T RM programs translated into a poor recall response despite T RM cell accumulation in the intestine. Reduced expression of MP/MF program genes in Bcl11b −/− T RM cells was linked to decreased chromatin accessibility and a reduction in activating histone marks at these loci. In contrast, the effector program genes displayed increased activating epigenetic status. These findings demonstrate that Bcl11b is a frontrunner in the tissue residency program of intestinal memory cells upstream of Tcf1 and Blimp1, promoting multipotency and restricting the effector program.